Label Decoder
Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding
Official label information
Neurontin labeling includes a pregnancy warning based on animal data (may cause fetal harm) and directs people to the North American AED Pregnancy Registry.
Plain-language explanation
Pregnancy and breastfeeding can change how risks and benefits are considered for a medicine. A clinician can help coordinate medication decisions with appropriate care.
What this often means for gabapentin products
Contact the prescriber if you are pregnant, planning pregnancy, or breastfeeding. Do not stop a seizure medicine suddenly because of a positive test. Registry enrollment, if eligible, is research support—not a treatment.
Ask your pharmacist
Ask who should review the medication list promptly if pregnancy status changes.
Sources
- DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine
- North American Antiepileptic Drug (NAAED) Pregnancy Registry — North American AED Pregnancy Registry
- MedlinePlus: Gabapentin — MedlinePlus / National Library of Medicine
This decoder does not diagnose, set a personal dose, or create a taper schedule. If two instructions conflict, pause and ask the dispensing pharmacist.